Ex-CEO's Counterclaims Not Allowed, Insys Trustee Says

By Ben Zigterman · January 23, 2024, 7:54 PM EST

The liquidation trustee of Insys Therapeutics on Tuesday asked a Delaware bankruptcy judge for an injunction preventing the pharmaceutical company's former CEO Michael L. Babich from pursuing counterclaims in a clawback...

To view the full article, register now.